| pubmed-article:9636831 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C0240951 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C0079459 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C0006141 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C0210630 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C1521721 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C0060133 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C2717829 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C0439185 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C1705938 | lld:lifeskim |
| pubmed-article:9636831 | lifeskim:mentions | umls-concept:C1527178 | lld:lifeskim |
| pubmed-article:9636831 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9636831 | pubmed:dateCreated | 1998-9-10 | lld:pubmed |
| pubmed-article:9636831 | pubmed:abstractText | Conventional dosages of cytostatics in mg/m2 will cause marked variations in systemic exposure, resulting in over- and under-treatment, at least with respect to side effects. | lld:pubmed |
| pubmed-article:9636831 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9636831 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9636831 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9636831 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9636831 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9636831 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9636831 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9636831 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9636831 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9636831 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9636831 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:9636831 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:9636831 | pubmed:author | pubmed-author:BergaSS | lld:pubmed |
| pubmed-article:9636831 | pubmed:author | pubmed-author:MalmströmPP | lld:pubmed |
| pubmed-article:9636831 | pubmed:author | pubmed-author:Kellokumpu-Le... | lld:pubmed |
| pubmed-article:9636831 | pubmed:author | pubmed-author:WilkinsBB | lld:pubmed |
| pubmed-article:9636831 | pubmed:author | pubmed-author:AnkerGG | lld:pubmed |
| pubmed-article:9636831 | pubmed:author | pubmed-author:EriksteinBB | lld:pubmed |
| pubmed-article:9636831 | pubmed:author | pubmed-author:BengtssonN... | lld:pubmed |
| pubmed-article:9636831 | pubmed:author | pubmed-author:FornanderTT | lld:pubmed |
| pubmed-article:9636831 | pubmed:author | pubmed-author:WiklundTT | lld:pubmed |
| pubmed-article:9636831 | pubmed:author | pubmed-author:BennmarkerHH | lld:pubmed |
| pubmed-article:9636831 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9636831 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:9636831 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9636831 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9636831 | pubmed:pagination | 403-11 | lld:pubmed |
| pubmed-article:9636831 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:meshHeading | pubmed-meshheading:9636831-... | lld:pubmed |
| pubmed-article:9636831 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9636831 | pubmed:articleTitle | Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401. | lld:pubmed |
| pubmed-article:9636831 | pubmed:affiliation | Department of Oncology, Akademiska sjukhuset, Uppsala, Sweden. jonas.bergh@oncology.uu.se | lld:pubmed |
| pubmed-article:9636831 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9636831 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9636831 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9636831 | lld:pubmed |
